Lopinavir pharmacokinetics in COVID-19 patients
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
The Journal of antimicrobial chemotherapy - 75(2020), 9 vom: 01. Sept., Seite 2702-2704 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gregoire, Matthieu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2494G1JF75 |
|---|
| Anmerkungen: |
Date Completed 02.09.2020 Date Revised 10.01.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jac/dkaa195 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310253756 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310253756 | ||
| 003 | DE-627 | ||
| 005 | 20231225135708.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jac/dkaa195 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310253756 | ||
| 035 | |a (NLM)32443151 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gregoire, Matthieu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lopinavir pharmacokinetics in COVID-19 patients |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.09.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Cytochrome P-450 CYP3A Inhibitors |2 NLM | |
| 650 | 7 | |a Lopinavir |2 NLM | |
| 650 | 7 | |a 2494G1JF75 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Le Turnier, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Gaborit, Benjamin J |e verfasserin |4 aut | |
| 700 | 1 | |a Veyrac, Gwenaelle |e verfasserin |4 aut | |
| 700 | 1 | |a Lecomte, Raphaël |e verfasserin |4 aut | |
| 700 | 1 | |a Boutoille, David |e verfasserin |4 aut | |
| 700 | 1 | |a Canet, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Imbert, Berthe-Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Bellouard, Ronan |e verfasserin |4 aut | |
| 700 | 1 | |a Raffi, François |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of antimicrobial chemotherapy |d 1981 |g 75(2020), 9 vom: 01. Sept., Seite 2702-2704 |w (DE-627)NLM000017701 |x 1460-2091 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2020 |g number:9 |g day:01 |g month:09 |g pages:2702-2704 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jac/dkaa195 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2020 |e 9 |b 01 |c 09 |h 2702-2704 | ||